Speaker(s): 

Nikki Polivka PharmD Candidate - Wilkes University - has nothing to disclose.

Moderator(s): 

Christopher DeFrancesco PharmD, Clinical Pharmacist - Geisinger; Faith Wellings PharmD, Asst Professor of Pharmacy Practice, Wilkes University - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Identify key changes to the updated 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes.

2. Describe the pharmacologic action and therapeutic use of medications pertinent to the management of ACS.

3. Apply the key changes from the guidelines to a patient case.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None